Company / Tangible Book Value per Share
Inhibrx Biosciences, Inc. Tangible Book Value per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.55
FY2025
5-year range
$0.55 / $3.69
FY2023-FY2025
Trend
-39.9%
vs FY2024
Sector context
#172 of 209
Health Care
What the data says
Inhibrx Biosciences, Inc.'s tangible book value per share of $0.55 is lower than 82% of companies in the Health Care sector (FY2025). Declined from $3.69 to $0.55 over the past 2 years.
Based on SEC 10-K filings.
0.55 in FY2025.
Declined from $3.69 to $0.55 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 209This company $0.55 Sector average $93.47
▼
-99.4% below sector average
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 39.9% year-over-year.
- Ranks #172 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.55 | -39.9% |
| FY2024 | $0.92 | -75.1% |
| FY2023 | $3.69 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026